Skip to main content
. 2019 Nov 29;9:17931. doi: 10.1038/s41598-019-54213-y

Figure 3.

Figure 3

Identification of biomarker risk signature for developing reversal reactions. Gene expression levels of 103 target genes were assessed by dual-color RT-MLPA performed on ex vivo RNA isolated from whole blood from BL/LL patients who developed reversal reactions (RR) at least two months later during the study (n = 30; grey circles) and BL/LL who did not develop reactions (n = 184; black circles) from Bangladesh, Brazil, Ethiopia and Nepal. Samples were analyzed at t = 0: in the absence of clinical signs of reactions. Log2-transformations of peak areas (normalized for GAPDH expression) of genes with significantly different expression between both groups (at t = 0) are shown on the y-axis. (A) Genes with a significant (p-value < 0.05) different expression only using the Mann-Whitney test are show. P-values were adjusted for multiple comparisons using the Benjamini-Hochberg correction40 (see Table S7). (B) Genes with a significant different expression in the global test and Mann-Whitney or the global test only are shown.